- Home
- PHAR vs LEU Comparison
PHAR vs LEU Comparison
Compare PHAR & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- LEU
- Stock Information
- Founded
- PHAR 1988
- LEU 1998
- Country
- PHAR Netherlands
- LEU United States
- Employees
- PHAR N/A
- LEU N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- PHAR Health Care
- LEU Industrials
- Exchange
- PHAR Nasdaq
- LEU Nasdaq
- Market Cap
- PHAR 679.0M
- LEU 1.2B
- IPO Year
- PHAR N/A
- LEU 1998
- Fundamental
- Price
- PHAR $9.29
- LEU $94.15
- Analyst Decision
- PHAR Strong Buy
- LEU Buy
- Analyst Count
- PHAR 3
- LEU 2
- Target Price
- PHAR $27.00
- LEU $92.00
- AVG Volume (30 Days)
- PHAR 6.7K
- LEU 623.8K
- Earning Date
- PHAR 03-13-2025
- LEU 02-06-2025
- Dividend Yield
- PHAR N/A
- LEU N/A
- EPS Growth
- PHAR N/A
- LEU 50.42
- EPS
- PHAR N/A
- LEU 4.70
- Revenue
- PHAR $285,745,000.00
- LEU $394,000,000.00
- Revenue This Year
- PHAR $20.08
- LEU $25.25
- Revenue Next Year
- PHAR $9.22
- LEU $5.68
- P/E Ratio
- PHAR N/A
- LEU $20.05
- Revenue Growth
- PHAR 30.64
- LEU 14.94
- 52 Week Low
- PHAR $6.65
- LEU $33.51
- 52 Week High
- PHAR $13.20
- LEU $118.36
- Technical
- Relative Strength Index (RSI)
- PHAR 48.44
- LEU 69.07
- Support Level
- PHAR $9.37
- LEU $68.10
- Resistance Level
- PHAR $10.01
- LEU $74.66
- Average True Range (ATR)
- PHAR 0.55
- LEU 5.84
- MACD
- PHAR -0.13
- LEU 2.60
- Stochastic Oscillator
- PHAR 13.82
- LEU 88.49
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.